<DOC>
	<DOCNO>NCT01328509</DOCNO>
	<brief_summary>The purpose propose project investigate measure zinc status relation oxidative stress inflammation patient sepsis . We hypothesise zinc depletion modulate inflammatory response , lead increase oxidative stress mitochondrial dysfunction . Sepsis severe infection lead cause death critically ill patient [ 1 ] . Zinc deficiency impairs overall immune function resistance infection [ 2 ] . In vitro exposure monocyte lipopolysaccharide ( LPS ) lead decreased cellular zinc content [ 3 ] zinc redistribution show human volunteer response LPS [ 4 ] . Zinc depletion occur hospitalize patient include infection , elderly , alcoholic , trauma burn [ 5-8 ] , condition common among critically ill patient sepsis . In mouse model sepsis , zinc depletion prior sepsis result inflammation severe organ injury increase mortality [ 9 ] . In patient sepsis , early feeding zinc result faster recovery organ function compare control [ 10 ] . Zinc status likely compromise critically ill zinc depletion may affect inflammatory response recovery . Although zinc antioxidant , bind metallothionein [ 11 ] zinc supplementation decrease oxidative stress [ 12 ] . Oxidative stress consistently report patient sepsis [ 13-15 ] . We recently show protection mitochondrial function antioxidant reduce organ damage rat [ 16 ] . Pentraxin-3 inflammatory marker regulate part antioxidant play key role innate immunity [ 17 ] . The consequence zinc deficiency may relate , part , effect nuclear factor NFκB , transcription factor crucial signalling network involve sepsis [ 18 ] . Higher NFκB activity associate increased mortality patient sepsis [ 19,20 ] . It likely compromise antioxidant defence inflammation occur consequence zinc deficiency . We propose measure plasma zinc metallothionein mRNA status relation inflammatory marker include key cytokine , pentraxin-3 , marker oxidative stress antioxidant status patient sepsis .</brief_summary>
	<brief_title>Zinc Inflammation Sepsis</brief_title>
	<detailed_description>Following ethical approval consent seek either patient , assent near relative . Successive patient admit Intensive Care Unit Aberdeen Royal Infirmary fulfil follow criterion sepsis , give , within 24h time window , include . - Clinical suspicion evidence acute infection - SIRS define two follow : 1 . Core temperature &lt; 36 degree C &gt; 38 degree C 2 . Tachycardia ; heart rate &gt; 90 beats/min . 3 . Tachypnoea ; respiratory rate &gt; 20 breaths/min mechanical ventilation 4 . White blood count &gt; 12 x 109/l &lt; 4 x 109/l In pilot study recruit 20 patient sepsis 20 critically ill patient clinical suspicion sepsis . Patients exclude &lt; 16 year , pregnant lactating , HIV positive , receiving corticosteroid know immuno-modulatory drug ( include statin ) , cancer autoimmune disorder consent/assent refuse . Blood sample obtain Days 1,2 , 5 , 10 14 ICU stay . Peripheral whole blood sample indwell arterial line plasma separate analysis plasma zinc use atomic absorption spectroscopy . Plasma interleukin-6 ( IL-6 ) pentraxin-3 ( PTX3 ) measure use enzyme immunoassay total antioxidant capacity lipid hydroperoxides measure colourimetrically [ 17 ] . Peripheral blood mononuclear cell ( MNC ) separate use single density gradient centrifugation , RNA extract metallothionein mRNA measure use qPCR [ 21 ] . Nuclear extract MNC prepared nuclear factor kappa B ( NFκB ) activation measure use enzyme immunoassay [ 17 ] .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<criteria>Patients sepsis admit ICU clinical suspicion evidence acute infection PLUS two follow : 1 . Core temperature &lt; 36 degree C &gt; 38 degree C 2 . Tachycardia ; heart rate &gt; 90 beats/min . 3 . Tachypnoea ; respiratory rate &gt; 20 breaths/min mechanical ventilation 4 . White blood count &gt; 12 x 10 9/l &lt; 4 x 10 9/l Control patient admit ICU clinical evidence suspicion infection 16 year old pregnant lactating HIV positive receiving corticosteroid know immunomodulatory drug treat statin last month cancer autoimmune disorder consent/assent refuse</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Zinc</keyword>
</DOC>